ReachMD

Be part of the knowledge.™

Oncology and Hematology

134

LikeLikedUnlike

Episodes 1-15 of 64

Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
CME/CE Live Broadcast
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 02, 2023
06:30 PM - 07:30 PM PDT
- Ezra Cohen, MD
  Peer
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
  Peer
- Deborah J. Wong, MD, PhD
  Peer
1.00 credits Learn more
CME/CE Meeting
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 02, 2023
06:30 PM - 07:30 PM PDT
- Ezra Cohen, MD
  Peer
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
  Peer
- Deborah J. Wong, MD, PhD
  Peer
1.00 credits Learn more
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
CME/CE Live Broadcast
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 09, 2023
12:00 PM - 01:00 PM EDT
- Ezra Cohen, MD
  Peer
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
  Peer
- Deborah J. Wong, MD, PhD
  Peer
1.00 credits Learn more
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
CME/CE
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
- Sarah Tinsley-Vance, PhD, MSN, APRN-BC, AOCN
  Peer
- Terran Sims, MSN, ACNP-C, CNN, COCN-C
  Peer
1.00 credits
Biomarker Testing in NSCLC: Who, What, When?
CME/CE
Biomarker Testing in NSCLC: Who, What, When?
- Rasheda Persinger MSN, AGNP-C, AOCNP
  Peer
- Terran Sims, MSN, ACNP-C, CNN, COCN-C
  Peer
1.00 credits
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
CME/CE
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
- Sarah Traverso, MMS, PA-C
  Peer
1.00 credits
Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
CME/CE
Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
- Mary Weinstein Dunn
  Peer
1.00 credits
Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A
CME/CE
Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A
- Guy Young, MD
  Peer
0.50 credits
MinuteCE®
Sickle Cell Disease Across the Life Span: What Your Patients Want You to Know
- Biree Andemariam, MD
  Peer
- Caroline Freiermuth, MD
  Peer
1.00 credits 10 episodes
Keeping Pace in Hematologic Malignancies: 2023
Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat Subtypes
CME/CE
Keeping Pace in Hematologic Malignancies: 2023
Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat Subtypes
- Harry Paul Erba, MD, PhD
  Peer
- Courtney DiNardo, MD
  Peer
0.50 credits
Incorporating Scientific Advances into Myelofibrosis Treatment Plans
CME/CE
Incorporating Scientific Advances into Myelofibrosis Treatment Plans
- Ruben Mesa, MD, FACP
  Peer
1.00 credits
Delivering Change: Mechanisms to Address Racial Healthcare Disparities in Multiple Myeloma
CME/CE
Delivering Change: Mechanisms to Address Racial Healthcare Disparities in Multiple Myeloma
- Joseph Mikhael, MD
  Peer
- Monique Hartley-Brown, MD
  Peer
- Brandon Blue, MD
  Peer
0.25 credits
In the Medical Spotlight: Antibody-Drug Conjugates in Advanced HER2-Positive Gastric/Gastroesophageal Junction Cancer
CME/CE
In the Medical Spotlight: Antibody-Drug Conjugates in Advanced HER2-Positive Gastric/Gastroesophageal Junction Cancer
- John L. Marshall, MD
  Peer
0.25 credits
Optimizing the Use of Immunotherapy in the First-Line Maintenance Setting for Metastatic Urothelial Carcinoma
CME/CE
Optimizing the Use of Immunotherapy in the First-Line Maintenance Setting for Metastatic Urothelial Carcinoma
- Petros Grivas, MD, PhD
  Peer
- Thomas Powles, MD, PhD
  Peer
0.50 credits
A Changing Approach to TNBC Management: Patients as Partners in Care
CME/CE
A Changing Approach to TNBC Management: Patients as Partners in Care
- Tiffany Traina, MD, FASCO
  Peer
- Gregory Vidal, MD, PhD
  Peer
- Stephanie Walker, RN
  Peer
1.00 credits

Program Chapters

Segment Chapters

Playlist:

Recommended